A Broad-Spectrum Abietane Diterpenoid Derivative that Targets Lipid II Cycle and Bacterial Membrane to Combat Multidrug Resistance
Yajing Li(Tianjin University of Technology), Dongliang Guan(Chinese Academy of Sciences), Zhiwei Ren(Jiangxi University of Traditional Chinese Medicine), Xiaolei Bian(Unknown), Du Hong Chen(Institute for Advanced Study), Xinxin Feng(Hunan University), Zhifu Chen(Army Medical University), Jinyong Zhang(Qingdao Agricultural University), Shu-Hui Liu(Advanced Research Institute), Xiaomei Fu(Jiangxi University of Traditional Chinese Medicine)
Cited by 4
Related Papers
Sulfonium, an Underestimated Moiety for Structural Modification, Alters the Antibacterial Profile of Vancomycin Against Multidrug‐Resistant Bacteria
|Angewandte Chemie International Edition|2019|92
Selective N-glycan editing on living cell surfaces to probe glycoconjugate function
|Nature Chemical Biology|2020|64
Extra Sugar on Vancomycin: New Analogues for Combating Multidrug-Resistant <i>Staphylococcus aureus</i> and Vancomycin-Resistant <i>Enterococci</i>
|Journal of Medicinal Chemistry|2017|59
Potentiation of Vancomycin: Creating Cooperative Membrane Lysis through a “Derivatization-for-Sensitization” Approach
|Journal of the American Chemical Society|2022|32
Design and synthesis of novel dual-cyclic RGD peptides for αvβ3 integrin targeting
|Bioorganic & Medicinal Chemistry Letters|2019|22